BRCA1 and neoplasm: One way to guarantee 100% test rates for all patients with ovarian cancer upon diagnosis would be to use “reflex” (i.e., guaranteed) tumour BRCA1/2 mutation testing as part of the pathology department work-up (Hoskins, 2018).